Xanodyne Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Xanodyne Pharmaceuticals, Inc.
Novartis is one of the latest companies to fail in its attempt to have a marketing authorization application fast-tracked at the European Medicines Agency. There was better news for BioMarin.
The European Medicines Agency today revealed the names of the latest new products it believes should be approved for use across the EU.
Myovant, Bayer and Rhythm Pharmaceuticals are among the companies that could soon learn whether the European Medicines Agency thinks their drugs are fit for approval.
The European Medicines Agency today announced the new medicines it believes should be approved for use across the EU.
- Specialty Pharmaceuticals